Jay Sial's most recent trade in Eterna Therapeutics Inc was a trade of 117,200 Stock Option (Right to buy) done . Disclosure was reported to the exchange on March 11, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Eterna Therapeutics Inc | Jay Sial | Chief Administration Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 117,200 | 117,200 | - | - | Stock Option (Right to buy) | |
Eterna Therapeutics Inc | Jay Sial | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 71,000 | 71,000 | - | - | Stock Option | |
Eterna Therapeutics Inc | Jay Sial | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 35,700 | 35,700 | - | - | Restricted Stock Unit |